Craig West

Craig West is the Senior Vice President of Investor Relations at Nanobiotix. Craig brings more than 20 years of experience including healthcare buy-side and sell-side investment experience, along with investor relations and corporate communications leadership in the biotech industry. Prior to Nanobiotix, Craig most recently served as Vice President of Investor Relations and Corporate Communications at Curis. Before Curis, Craig served as head of investor relations at Epizyme and at BeiGene where he managed BeiGene’s global IR team in the United States and Asia for the company which had its shares ultimately trading on three major exchanges (U.S. Nasdaq, Hong Kong, Shanghai). His most recent investment experience was in buy-side analysis in the healthcare sector at Scout Investments and Guggenheim Partners, where he was Director of Research. His investment career began at the sell-side firm A.G. Edwards & Sons where he and a partner formed and grew the company’s biotech coverage team while he progressed through positions of increasing responsibility.